Drugs & Targets Clairity becomes the first FDA-authorized AI platform for breast cancer prediction June 06, 2025Vol.51 No.22
Drugs & Targets China’s NMPA approves zanidatamab in China for previously treated, unresectable or metastatic HER2+ biliary tract cancer June 06, 2025Vol.51 No.22
Pfizer seeks to improve breast cancer outcomes in Sub-Saharan AfricaWith help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries May 30, 2025Vol.51 No.21By Claire Marie Porter
Clinical Roundup Most Americans unaware of cancer risks associated with drinking alcohol May 30, 2025Vol.51 No.21
Cancer Policy Legislation to increase access to breast and cervical cancer screening introduced in the Senate May 23, 2025Vol.51 No.20
Clinical Roundup Breast implant closes reconstruction gap for patients after mastectomy May 16, 2025Vol.51 No.19
Clinical Roundup Incidence rates of some cancer types have risen in people under age 50, NCI study shows May 09, 2025Vol.51 No.18
Clinical Roundup Enhertu demonstrates superior efficacy over standard of care in HER2+ metastatic breast cancer April 25, 2025Vol.51 No.16
In Brief Hope Rugo named director of City of Hope’s Women’s Cancers Program April 18, 2025Vol.51 No.15
Clinical Roundup Researchers explore adapted Argentine tango dance therapy for cancer survivors at Ohio State April 18, 2025Vol.51 No.15
